BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11550996)

  • 1. PPARS in inflammation, atherosclerosis and thrombosis.
    Duez H; Fruchart JC; Staels B
    J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors in inflammation control.
    Delerive P; Fruchart JC; Staels B
    J Endocrinol; 2001 Jun; 169(3):453-9. PubMed ID: 11375115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.
    Chinetti G; Gbaguidi FG; Griglio S; Mallat Z; Antonucci M; Poulain P; Chapman J; Fruchart JC; Tedgui A; Najib-Fruchart J; Staels B
    Circulation; 2000 May; 101(20):2411-7. PubMed ID: 10821819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.
    Chinetti G; Griglio S; Antonucci M; Torra IP; Delerive P; Majd Z; Fruchart JC; Chapman J; Najib J; Staels B
    J Biol Chem; 1998 Oct; 273(40):25573-80. PubMed ID: 9748221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical interest of PPARs ligands.
    Vergès B
    Diabetes Metab; 2004 Feb; 30(1):7-12. PubMed ID: 15029092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lipid and lipoprotein metabolism by PPAR activators.
    Gervois P; Torra IP; Fruchart JC; Staels B
    Clin Chem Lab Med; 2000 Jan; 38(1):3-11. PubMed ID: 10774955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
    Ricote M; Valledor AF; Glass CK
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs: transcription factors controlling lipid and lipoprotein metabolism.
    Bocher V; Pineda-Torra I; Fruchart JC; Staels B
    Ann N Y Acad Sci; 2002 Jun; 967():7-18. PubMed ID: 12079830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PPARgamma and atheroma].
    Staels B
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S23-6. PubMed ID: 12037504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
    Marx N; Libby P; Plutzky J
    J Cardiovasc Risk; 2001 Aug; 8(4):203-10. PubMed ID: 11550998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
    Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
    Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of vascular inflammation by PPARs.
    Tham DM; Wang YX; Rutledge JC
    Drug News Perspect; 2003 Mar; 16(2):109-16. PubMed ID: 12792672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.